Li J, Ma J, Cao R, Zhang Q, Li M, Wang W
Nat Commun. 2025; 16(1):2513.
PMID: 40082449
PMC: 11906866.
DOI: 10.1038/s41467-025-57610-2.
Cristani M, Citarella A, Carnamucio F, Micale N
Biomolecules. 2024; 14(8).
PMID: 39199418
PMC: 11352298.
DOI: 10.3390/biom14081031.
Tanabe K, Zahrieh D, Strand C, Hoshida Y, Flotte T, DellaZanna G
Gastro Hep Adv. 2024; 3(3):426-439.
PMID: 39131140
PMC: 11307768.
DOI: 10.1016/j.gastha.2024.01.009.
Guo X, Luo W, Wu L, Zhang L, Chen Y, Li T
Adv Sci (Weinh). 2024; 11(35):e2403388.
PMID: 39033533
PMC: 11425287.
DOI: 10.1002/advs.202403388.
Gu W, Zeng Q, Wang X, Jasem H, Ma L
J Inflamm Res. 2024; 17:3801-3813.
PMID: 38887753
PMC: 11182363.
DOI: 10.2147/JIR.S464838.
Dietary licorice enhances in vivo cadmium detoxification and modulates gut microbial metabolism in mice.
Zheng X, Wang L, You L, Liu Y, Cohen M, Tian S
Imeta. 2024; 1(1):e7.
PMID: 38867726
PMC: 10989944.
DOI: 10.1002/imt2.7.
Glycyrrhizic Acid Nanoparticles Subside the Activity of Methicillin-Resistant by Suppressing PBP2a.
Rijo P, Abuamara T, Ali Lashin L, Kamar S, Isca V, Mohammed T
Pharmaceuticals (Basel). 2024; 17(5).
PMID: 38794159
PMC: 11123903.
DOI: 10.3390/ph17050589.
AI-assisted literature exploration of innovative Chinese medicine formulas.
Chung M, Su L, Chen C, Wu L
Front Pharmacol. 2024; 15:1347882.
PMID: 38584602
PMC: 10995307.
DOI: 10.3389/fphar.2024.1347882.
Precision targeting in hepatocellular carcinoma: Exploring ligand-receptor mediated nanotherapy.
Zhou X, Li Y, Dang S
World J Hepatol. 2024; 16(2):164-176.
PMID: 38495282
PMC: 10941735.
DOI: 10.4254/wjh.v16.i2.164.
Therapeutic approaches for chronic hepatitis C: a concise review.
Nawaz A, Manzoor A, Ahmed S, Ahmed N, Abbas W, Mir M
Front Pharmacol. 2024; 14:1334160.
PMID: 38283838
PMC: 10811011.
DOI: 10.3389/fphar.2023.1334160.
Network pharmacology and in vitro experimental verification unveil glycyrrhizin from glycyrrhiza glabra alleviates acute pancreatitis via modulation of MAPK and STAT3 signaling pathways.
Zhang R, Asikaer A, Chen Q, Wang F, Lan J, Liu Y
BMC Complement Med Ther. 2024; 24(1):58.
PMID: 38280993
PMC: 10821312.
DOI: 10.1186/s12906-024-04372-x.
Integrating Metabolomics and Network Pharmacology to Decipher the Hepatoprotective Effect Mechanisms of Magnesium Isoglycyrrhizinate Injection.
Zhang Y, Li H, Liu X, Wang Q, Zhao D, Su M
Curr Issues Mol Biol. 2024; 46(1):279-298.
PMID: 38248321
PMC: 10813909.
DOI: 10.3390/cimb46010019.
Liquorice Toxicity: A Comprehensive Narrative Review.
Ceccuzzi G, Rapino A, Perna B, Costanzini A, Farinelli A, Fiorica I
Nutrients. 2023; 15(18).
PMID: 37764649
PMC: 10537237.
DOI: 10.3390/nu15183866.
Advances in the roles of glycyrrhizic acid in cancer therapy.
Zhang Y, Sheng Z, Xiao J, Li Y, Huang J, Jia J
Front Pharmacol. 2023; 14:1265172.
PMID: 37649893
PMC: 10463042.
DOI: 10.3389/fphar.2023.1265172.
Exploring opportunities for drug repurposing and precision medicine in cannabis use disorder using genetics.
Greco L, Reay W, Dayas C, Cairns M
Addict Biol. 2023; 28(8):e13313.
PMID: 37500481
PMC: 10909568.
DOI: 10.1111/adb.13313.
Glycyrrhizic acid glycosides reduces extensive tripterygium glycosides-induced lipid deposition in hepatocytes.
Yang Y, Fu X, Xia B, Zhou L, Zhang H, Li C
Heliyon. 2023; 9(7):e17891.
PMID: 37483744
PMC: 10362073.
DOI: 10.1016/j.heliyon.2023.e17891.
Effect of Licorice Essential Oil () on Performance and Some Biochemical Parameters of Broiler Chickens.
Dheyauldeen Salahdin O, Othman H, Hafsan H, Mohammed F, Ahmed Hamza T, Kadhim M
Arch Razi Inst. 2023; 78(1):95-105.
PMID: 37312740
PMC: 10258287.
DOI: 10.22092/ARI.2022.359522.2442.
A Review of the Antiviral Activities of Glycyrrhizic Acid, Glycyrrhetinic Acid and Glycyrrhetinic Acid Monoglucuronide.
Zuo J, Meng T, Wang Y, Tang W
Pharmaceuticals (Basel). 2023; 16(5).
PMID: 37242424
PMC: 10223068.
DOI: 10.3390/ph16050641.
Liver manifestations in COVID-19 patients: A review article.
Helou M, Nasr J, El Osta N, Jabbour E, Husni R
World J Clin Cases. 2023; 11(10):2189-2200.
PMID: 37122526
PMC: 10131011.
DOI: 10.12998/wjcc.v11.i10.2189.
Natural Products as a Potential Source of Promising Therapeutics for COVID-19 and Viral Diseases.
Bafandeh S, Khodadadi E, Ganbarov K, Asgharzadeh M, Kose S, Kafil H
Evid Based Complement Alternat Med. 2023; 2023:5525165.
PMID: 37096202
PMC: 10122587.
DOI: 10.1155/2023/5525165.